
Sino Biopharm, together with its subsidiaries, is a leading, innovative research and development driven pharmaceutical conglomerate in China, with a business scope that is vertically integrated including research and development, manufacturing and sales and marketing infrastructure. Its product offerings include a variety of biological drugs and chemical drugs, and in the therapeutics areas including as hepatology, oncology, cardiovascular and cerebrovascular diseases, orthopedics, digestive, immune and respiratory diseases.